UnknownNot Applicable

Effects of Conventional Versus Skeletally Anchored Facemask in Treatment of the Prepubertal Skeletal Class III Patients

Egypt14 participantsStarted 2021-11-22

Plain-language summary

The aim of this study will be directed to the assessment of dentoskeletal effects concomitant with skeletally anchored maxillary protraction in orthodontic skeletal Class III patients.

Who can participate

Age range

8 Years – 14 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Growing Class III patients with a prepubertal stage of skeletal maturity according to the cervical vertebral maturation method. * Skeletal Class III malocclusion with maxillary deficiency (ANB, \<0°; N perp-A\<1mm) with or without mild mandibular prognathism. * Late mixed or early permanent dentition at the start of treatment characterized by a Wits appraisal of -1 mm or less and an Angle Class III molar relationship or anterior crossbite. * Vertically normal growth pattern determined by cephalometric radiographs. * Patients are free from developmental or congenital conditions such as cleft lip/palate or other craniofacial anomalies. * No previous orthodontic treatment. Exclusion Criteria: * Poor oral hygiene or periodontally compromised patient. * Patients with craniofacial anomalies or previous history of trauma, bruxism, or parafunctions. * Previous orthodontic treatment.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

midfacial length

Timeframe: 1 year

Trial details

NCT IDNCT05089396

SponsorAl-Azhar University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-07

Contact for this trial

Amr Embaby, BDS

00201016579279 amrembaby.209@azhar.edu.eg

View on ClinicalTrials.gov More Maxillary Deficiency trials

Who can participate

Age range

8 Years – 14 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.